253 related articles for article (PubMed ID: 25003325)
1. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.
Shao D; Perros F; Caramori G; Meng C; Dormuller P; Chou PC; Church C; Papi A; Casolari P; Welsh D; Peacock A; Humbert M; Adcock IM; Wort SJ
Biochem Biophys Res Commun; 2014 Aug; 451(1):8-14. PubMed ID: 25003325
[TBL] [Abstract][Full Text] [Related]
2. ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells.
Aoki S; Hayakawa M; Ozaki H; Takezako N; Obata H; Ibaraki N; Tsuru T; Tominaga S; Yanagisawa K
Mol Cell Biochem; 2010 Feb; 335(1-2):75-81. PubMed ID: 19756962
[TBL] [Abstract][Full Text] [Related]
3. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.
Demyanets S; Kaun C; Pentz R; Krychtiuk KA; Rauscher S; Pfaffenberger S; Zuckermann A; Aliabadi A; Gröger M; Maurer G; Huber K; Wojta J
J Mol Cell Cardiol; 2013 Jul; 60():16-26. PubMed ID: 23567618
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
[TBL] [Abstract][Full Text] [Related]
6. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.
Bartunek J; Delrue L; Van Durme F; Muller O; Casselman F; De Wiest B; Croes R; Verstreken S; Goethals M; de Raedt H; Sarma J; Joseph L; Vanderheyden M; Weinberg EO
J Am Coll Cardiol; 2008 Dec; 52(25):2166-74. PubMed ID: 19095135
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension.
Carlomagno G; Messalli G; Melillo RM; Stanziola AA; Visciano C; Mercurio V; Imbriaco M; Ghio S; Sofia M; Bonaduce D; Fazio S
Int J Cardiol; 2013 Sep; 168(2):1545-7. PubMed ID: 23290950
[No Abstract] [Full Text] [Related]
8. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
Miller AM; Liew FY
Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production.
Choi YS; Choi HJ; Min JK; Pyun BJ; Maeng YS; Park H; Kim J; Kim YM; Kwon YG
Blood; 2009 Oct; 114(14):3117-26. PubMed ID: 19661270
[TBL] [Abstract][Full Text] [Related]
10. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue.
Zeyda M; Wernly B; Demyanets S; Kaun C; Hämmerle M; Hantusch B; Schranz M; Neuhofer A; Itariu BK; Keck M; Prager G; Wojta J; Stulnig TM
Int J Obes (Lond); 2013 May; 37(5):658-65. PubMed ID: 22828942
[TBL] [Abstract][Full Text] [Related]
11. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
[TBL] [Abstract][Full Text] [Related]
12. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
13. Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.
Lin CY; Pfluger CM; Henderson RD; McCombe PA
J Neuroimmunol; 2012 Aug; 249(1-2):93-5. PubMed ID: 22633272
[TBL] [Abstract][Full Text] [Related]
14. IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
Liu J; Wang W; Wang L; Chen S; Tian B; Huang K; Corrigan CJ; Ying S; Wang W; Wang C
EBioMedicine; 2018 Jul; 33():196-210. PubMed ID: 29921553
[TBL] [Abstract][Full Text] [Related]
15. ST2 and IL-33 in pregnancy and pre-eclampsia.
Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
[TBL] [Abstract][Full Text] [Related]
16. A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
Lin J; Zhang L; Zhao G; Su Z; Deng R; Pflugfelder SC; Li DQ
PLoS One; 2013; 8(4):e60963. PubMed ID: 23585867
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Pastorelli L; Garg RR; Hoang SB; Spina L; Mattioli B; Scarpa M; Fiocchi C; Vecchi M; Pizarro TT
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):8017-22. PubMed ID: 20385815
[TBL] [Abstract][Full Text] [Related]
18. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis.
Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P
Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913
[TBL] [Abstract][Full Text] [Related]
19. IL-33 mediates inflammatory responses in human lung tissue cells.
Yagami A; Orihara K; Morita H; Futamura K; Hashimoto N; Matsumoto K; Saito H; Matsuda A
J Immunol; 2010 Nov; 185(10):5743-50. PubMed ID: 20926795
[TBL] [Abstract][Full Text] [Related]
20. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
